Neurological and Cognitive Dysfunction Following CAR-T Treatment. ICANS and Beyond
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Clinical Trials Related to ICANS
Related studies linked through entity extraction aliases.
Adjunctive Methylene Blue for Immunotherapy-related CRS and ICANS: Phase I Study
- Status
- RECRUITING
- Phase
- PHASE1
Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2